The Association of EGFR Mutations with Stage at Diagnosis in Lung Adenocarcinomas.
Jaeyoung ChoSun Mi ChoiJinwoo LeeChang-Hoon LeeSang-Min LeeJae-Joon YimDoo Hyun ChungChul-Gyu YooYoung Whan KimSung Koo HanYoung Sik ParkPublished in: PloS one (2016)
The presence of EGFR mutations is significantly associated with early stage disease at initial diagnosis in lung adenocarcinomas after adjusting for age, sex, smoking status, and screening. This finding implies that EGFR mutations may play a role as a positive prognostic marker.